HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients
Go back to HeartBeam Joins European EXIT-CVD Research Consortium to Advance At-Home ECG Monitoring for Early Detection of Acute Coronary Syndrome (ACS) in High-Risk Patients| BIOTELEMETRY (NASDAQ: BEAT) | Delayed: 0.40 -0.01 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.41 | 52 Week High | $21.68 | |||
| Open | $0.41 | 52 Week Low | $8.74 | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.39 | EPS | $-0.46 | |||
| Volume | 592,735 | |||||



